CNX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is technically oversold, and Q1 earnings beat expectations, but the broader setup is mixed: price is below key resistance, momentum is weak, analyst sentiment is mostly bearish, and hedge funds are selling aggressively. Since the user is impatient and does not want to wait for optimal entry points, I would not call this a buy today. The better call is to hold and wait for clearer trend confirmation.
CNX closed at 36.00, slightly above the prior close of 35.92, but the broader short-term trend remains weak. MACD histogram is -0.211 and negatively expanding, which confirms bearish momentum. RSI_6 at 19.252 signals the stock is deeply oversold, so a rebound is possible, but oversold alone is not enough to confirm a durable uptrend. Moving averages are converging, suggesting a potential turning point, yet price is still trading near support (S1 36.169 and S2 35.171) and below pivot resistance at 37.785. Overall trend: weak, oversold, and not yet confirmed bullish.

Q1 results were strong: revenue beat expectations and grew 67.1% year over year in the news summary, and adjusted EPS of $1.20 beat forecasts by 23.7%. The company also benefits from Marcellus infrastructure investments that improved well economics and reduced operating costs. Its long-term hedging strategy has helped lock in favorable pricing and reduce refinancing risk. RSI is deeply oversold, which could support a short-term bounce.
Analyst sentiment is mostly negative, with multiple Underweight/Underperform/Sell ratings and recent price target cuts. Hedge funds have been selling, with selling up 282.18% over the last quarter. Technical momentum is weak, with MACD bearish and price sitting below pivot resistance. Stock-trend modeling also points to slightly negative returns over the next day, week, and month. No AI Stock Picker or SwingMax buy signal is present today.
In Q1 2026, CNX showed strong top-line growth, with revenue up 30.59% year over year to 734.7 million. Gross margin improved to 61.91%, up 17.05% YoY, which supports better operating efficiency. However, net income fell to 348.1 million and EPS dropped to 2.18 YoY, indicating that profitability metrics were uneven despite revenue growth. The latest quarter season was Q1 2026.
Recent analyst revisions show a cautious to bearish Wall Street view. BofA lowered its target to $34 and kept Underperform. Morgan Stanley raised target to $34 but stayed Underweight. Truist initiated at Sell with a $35 target. JPMorgan raised target to $39 but remained Neutral, and Mizuho raised target to $44 while staying Neutral. Barclays raised target to $36 but kept Underweight. Overall, pros acknowledge stronger energy prices and cash flow support, but the dominant view is still skeptical on CNX relative to peers. Politicians or other influential figures: no recent politician or influential figure trading activity was reported. Congress trading data: none available.